PubMed COVID-19 Clinical Care

CONCLUSIONS: Mesenchymal stem cells can reduce the mortality of COVID-19 patients.

CONCLUSION: Our single-center real-life experience is in line with recently published research, revealing no benefit from TCZ routine use in severely or critically ill patients with COVID-19.

While COVID-19 has accelerated digital transformation, increasing labor costs and 52-h workweek rules are replacing human labor with self-service technologies (SSTs). Self-service technology is increasingly being implemented in restaurant settings

Respiratory diseases such as cystic fibrosis, COPD, and COVID-19 are difficult to treat owing to viscous secretions in the airways that evade mucocilliary clearance. Earlier studies have shown success with BromAc as a mucolytic agent. Hence, we

Since November 2019, most countries across the globe have suffered from the disastrous consequences of the Covid-19 pandemic which redefined every aspect of human life. Given the inevitable spread and transmission of the virus, it is critical to

CONCLUSIONS: During the outbreak of the epidemic or pandemic, adequate psychological care resources need to be provided to nurses when facing the death of infectious patients, to reduce the negative emotions brought by death. Effective coping

No abstract

In this work, the COVID-19 pandemic burden in Ukraine is investigated retrospectively using the excess mortality measures during 2020-2021. In particular, the epidemic impact on the Ukrainian population is studied via the standardized both all-cause

Hemoperfusion has been considered a promising adjuvant treatment for chronic diseases and some acute states when specific removal of pathogenic factors from the bloodstream is desired. Over the years, advances in adsorption materials (e.g., new

俯卧位通气作为治疗急性呼吸窘迫综合征的重要组成部分，可使肺通气更均一及通气血流比更匹配，降低肺损伤的发生率及保护右心功能，改善氧合，降低病死率。俯卧位通气治疗可缓解新型冠状病毒感染患者的低氧血症，降低再插管率及改善患者预后。与传统急性呼吸窘迫综合征比，俯卧位通气治疗新型冠状病毒感染相关低氧血症的机制可能有所不同，仍有一些问题需要进一步厘清。同时必须注意，实施俯卧位通气治疗需要熟练的医护团队及密切监测，更需要警惕实施过程中的不良事件。.